Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2007)
All Articles published online
|
Oct 7, 2006 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | R RZ, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy. World J Gastroenterol 2006; 12(37): 6032-6036 [PMID: 17009404 DOI: 10.3748/wjg.v12.i37.6032] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i37/6032.htm |
| Number | Citing Articles |
| 1 |
Lucy Gossage, Srinivasan Madhusudan. Cancer Pharmacogenomics. Molecular Diagnosis & Therapy 2007; 11(6): 361 doi: 10.1007/BF03256260
|
| 2 |
YONG-PING LIU, YANG LING, QIU-FENG QI, YA-PING ZHANG, CHANG-SONG ZHANG, CHANG-TAI ZHU, MEI-HUA WANG, YAO-DONG PAN. Genetic polymorphisms of ERCC1-118, XRCC1-399 and GSTP1-105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin-based adjuvant chemotherapy. Molecular Medicine Reports 2013; 7(6): 1904 doi: 10.3892/mmr.2013.1435
|
| 3 |
Qiong Yang, Ying Wei, Yan-Xian Chen, Si-Wei Zhou, Zhi-Min Jiang, De-Rong Xie. Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/634929
|
| 4 |
Kakoli Das, Patrick Tan. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; : 105 doi: 10.1007/978-1-62703-456-2_7
|
| 5 |
H. Chu, D. Gu, M. Xu, Z. Xu, Y. Gong, W. Gong, Y. Tang, J. Zhou, N. Tong, Z. Zhang, J. Chen, M. Wang. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis 2013; 28(4): 441 doi: 10.1093/mutage/get023
|
| 6 |
Jing Li, Martin H. Bluth, Andrea Ferreira-Gonzalez. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; : 1359 doi: 10.1016/B978-1-4377-0974-2.00072-5
|
| 7 |
Jiun‐I. Lai, Cheng‐Hwai Tzeng, Po‐Min Chen, Jen‐Kou Lin, Tzu‐Chen Lin, Wei‐Shone Chen, Jeng‐Kae Jiang, Huann‐Sheng Wang, Wei‐Shu Wang. Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX‐4 treatment in Asian patients with colorectal carcinoma. Cancer Science 2009; 100(7): 1261 doi: 10.1111/j.1349-7006.2009.01186.x
|
| 8 |
Ayse Basak Engin, Bensu Karahalil, Atilla Engin, Ali Esat Karakaya. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma. Molecular Biology Reports 2011; 38(8): 5379 doi: 10.1007/s11033-011-0690-9
|
| 9 |
Luis Alberto Henríquez-Hernández, Almudena Valenciano, Estefanía Herrera-Ramos, Marta Lloret, Alba Riveros-Perez, Pedro C. Lara. High-throughput genotyping system as a robust and useful tool in oncology: Experience from a single institution. Biologicals 2013; 41(6): 424 doi: 10.1016/j.biologicals.2013.09.006
|
| 10 |
Emilia Balboa, Goretti Duran, Maria Jesus Lamas, Antonio Gomez-Caamaño, Catuxa Celeiro-Muñoz, Rafael Lopez, Angel Carracedo, Francisco Barros. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. Pharmacogenomics 2010; 11(6): 747 doi: 10.2217/pgs.10.51
|
| 11 |
Yangkai Li, Zhensheng Liu, Hongliang Liu, Li-E Wang, Dongfeng Tan, Jaffer A. Ajani, Qing-Yi Wei, Xiaoping Miao. ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients. PLoS ONE 2013; 8(9): e71994 doi: 10.1371/journal.pone.0071994
|
| 12 |
Karen De Souza, Suha Atabani, Srinivasan Madhusudan. Precision medicine in gastric cancer: where are we now?. Expert Review of Precision Medicine and Drug Development 2017; 2(4): 193 doi: 10.1080/23808993.2017.1357431
|
| 13 |
Xi‐Dai Long, Yun Ma, Yong‐Zhi Huang, Yun Yi, Qiu‐Xiang Liang, Ai‐Min Ma, Li‐Ping Zeng, Guo‐Hui Fu. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection‐related gastric antrum adenocarcinoma in Guangxi population, China. Molecular Carcinogenesis 2010; 49(6): 611 doi: 10.1002/mc.20630
|
| 14 |
Ayse Basak Engin, Bensu Karahalil, Atilla Engin, Ali Esat Karakaya. Oxidative Stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln Polymorphisms in a Turkish Population with Colorectal Carcinoma. Genetic Testing and Molecular Biomarkers 2010; 14(4): 559 doi: 10.1089/gtmb.2009.0195
|
| 15 |
Christina Perry, Rebeka Sultana, Srinivasan Madhusudan. DNA Repair in Cancer Therapy. 2012; : 257 doi: 10.1016/B978-0-12-384999-1.10012-5
|
| 16 |
Hee Seung Kim, Mi-Kyung Kim, Hyun Hoon Chung, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, Soon Beom Kang. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study. Gynecologic Oncology 2009; 113(2): 264 doi: 10.1016/j.ygyno.2009.01.002
|
| 17 |
Delphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat, Gérard Milano. The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. Cancer Treatment Reviews 2012; 38(6): 737 doi: 10.1016/j.ctrv.2012.02.004
|